UNSPSC 51281656: Neomycin b sulphate

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13.3H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3720KZ4TQ, chemically known as neomycin b, sulfate (salt), but more generally known as neomycin b sulphate, which bears US NIH Compound Identifier 197162. European Medicines Agency schedules neomycin b sulphate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG.

Most nations, for tariff purposes, schedule neomycin b sulphate under HS 29419000. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.

UNSPSC 51281656 Neomycin b sulphate is a Commodity code that state and local governments procure as part of broader medical supply, pharmaceutical, and emergency response acquisitions rather than as a standalone product line. Recent solicitations show that the code captures activity where neomycin and similar pharmaceutical inputs are components within larger medical and first aid supply contracts, healthcare program procurements, and pharmaceutical distribution agreements. The issuing bodies span county health departments, municipal fire rescue divisions, state health and human services agencies, and multistate cooperative purchasing alliances. Scope ranges from emergency medical consumables (respiratory equipment, cardiac monitoring devices, bandaging materials, and airway supplies) procured by municipal fire departments to generic multi-source pharmaceutical manufacturing and distribution agreements serving state and local healthcare systems across multiple jurisdictions.

Recent activity centers on Florida, Texas, and Minnesota, with multistate reach through cooperative purchasing vehicles. The City of Tampa issued IFB 26P00145 on March 25, 2026 for medical and first aid supplies ($700,000 estimated value) with a March 13, 2026 response date, designated as a sheltered Small Local Business Enterprise opportunity with a 5 percent bid discount. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, with a July 26, 2023 response deadline and potential FEMA funding. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through MMCAP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with a March 26, 2026 proposal deadline and July 1, 2026 contract effective date. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, representing exploratory procurement activity preceding formal RFP issuance.